Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Lindhagen

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Plos One|April 8, 2021
Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registryKai M Eggers, Lars Lindhagen, Tomasz Baron, et al.
JAMA|February 18, 2015
Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarctionKarolina Szummer, Jonas Oldgren, Lars Lindhagen, et al.
European Heart Journal|October 12, 2017
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014Karolina Szummer, Lars Wallentin, Lars Lindhagen, et al.
European Heart Journal|September 22, 2018
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014Karolina Szummer, Lars Wallentin, Lars Lindhagen, et al.
European Heart Journal|September 11, 2019
Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registryMoa Simonsson, Lars Wallentin, Joakim Alfredsson, et al.
American Heart Journal|March 29, 2025
HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients with acute Myocardial Infarction (HELP-MI SWEDEHEART) - Design and rationale of a cluster randomized, crossover, registry-based clinical trialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
Lancet (London, England)|September 3, 2016
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre studyLars Wallentin, Lars Lindhagen, Elisabet Ärnström, et al.
Clinical Chemistry|May 11, 2019
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary ArteriesMarcus Hjort, Kai M Eggers, Lars Lindhagen, et al.
JAMA|September 1, 2025
Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART TrialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Plos One|April 8, 2021
Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registryKai M Eggers, Lars Lindhagen, Tomasz Baron, et al.
JAMA|February 18, 2015
Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarctionKarolina Szummer, Jonas Oldgren, Lars Lindhagen, et al.
European Heart Journal|October 12, 2017
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014Karolina Szummer, Lars Wallentin, Lars Lindhagen, et al.
European Heart Journal|September 22, 2018
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014Karolina Szummer, Lars Wallentin, Lars Lindhagen, et al.
European Heart Journal|September 11, 2019
Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registryMoa Simonsson, Lars Wallentin, Joakim Alfredsson, et al.
American Heart Journal|March 29, 2025
HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients with acute Myocardial Infarction (HELP-MI SWEDEHEART) - Design and rationale of a cluster randomized, crossover, registry-based clinical trialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
Lancet (London, England)|September 3, 2016
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre studyLars Wallentin, Lars Lindhagen, Elisabet Ärnström, et al.
Clinical Chemistry|May 11, 2019
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary ArteriesMarcus Hjort, Kai M Eggers, Lars Lindhagen, et al.
JAMA|September 1, 2025
Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART TrialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
Pageof 5